166 related articles for article (PubMed ID: 35211690)
1. Detecting molecular subtypes from multi-omics datasets using SUMO.
Sienkiewicz K; Chen J; Chatrath A; Lawson JT; Sheffield NC; Zhang L; Ratan A
Cell Rep Methods; 2022 Jan; 2(1):. PubMed ID: 35211690
[TBL] [Abstract][Full Text] [Related]
2. Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline.
Sienkiewicz K; Ratan A
STAR Protoc; 2022 Mar; 3(1):101110. PubMed ID: 35106500
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Characteristics of
Chang YZ; Li GZ; Pang B; Zhang KN; Zhang XH; Wang YZ; Jiang ZL; Chai RC
Front Cell Dev Biol; 2020; 8():580464. PubMed ID: 33195221
[No Abstract] [Full Text] [Related]
4. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
[TBL] [Abstract][Full Text] [Related]
5. Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping.
Madhumita ; Paul S
Comput Biol Med; 2022 Sep; 148():105832. PubMed ID: 35834966
[TBL] [Abstract][Full Text] [Related]
6. Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
Tesileanu CMS; Dirven L; Wijnenga MMJ; Koekkoek JAF; Vincent AJPE; Dubbink HJ; Atmodimedjo PN; Kros JM; van Duinen SG; Smits M; Taphoorn MJB; French PJ; van den Bent MJ
Neuro Oncol; 2020 Apr; 22(4):515-523. PubMed ID: 31637414
[TBL] [Abstract][Full Text] [Related]
7. T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.
Patel SH; Poisson LM; Brat DJ; Zhou Y; Cooper L; Snuderl M; Thomas C; Franceschi AM; Griffith B; Flanders AE; Golfinos JG; Chi AS; Jain R
Clin Cancer Res; 2017 Oct; 23(20):6078-6085. PubMed ID: 28751449
[No Abstract] [Full Text] [Related]
8. Randomized singular value decomposition for integrative subtype analysis of 'omics data' using non-negative matrix factorization.
Ni Y; He J; Chalise P
Stat Appl Genet Mol Biol; 2023 Jan; 22(1):. PubMed ID: 37937887
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
Lu VM; O'Connor KP; Shah AH; Eichberg DG; Luther EM; Komotar RJ; Ivan ME
J Neurooncol; 2020 Jun; 148(2):221-229. PubMed ID: 32385699
[TBL] [Abstract][Full Text] [Related]
10. Multi-view spectral clustering with latent representation learning for applications on multi-omics cancer subtyping.
Ge S; Liu J; Cheng Y; Meng X; Wang X
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36445207
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
12. Subtype-DCC: decoupled contrastive clustering method for cancer subtype identification based on multi-omics data.
Zhao J; Zhao B; Song X; Lyu C; Chen W; Xiong Y; Wei DQ
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36702755
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines.
Kumari K; Dandapath I; Singh J; Rai HIS; Kaur K; Jha P; Malik N; Chosdol K; Mallick S; Garg A; Suri A; Sharma MC; Sarkar C; Suri V
Appl Immunohistochem Mol Morphol; 2022 Jul; 30(6):410-417. PubMed ID: 35708480
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
16. MRGCN: cancer subtyping with multi-reconstruction graph convolutional network using full and partial multi-omics dataset.
Yang B; Yang Y; Wang M; Su X
Bioinformatics; 2023 Jun; 39(6):. PubMed ID: 37255323
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics data fusion using adaptive GTO guided Non-negative matrix factorization for cancer subtype discovery.
Bansal B; Sahoo A
Comput Methods Programs Biomed; 2023 Jan; 228():107246. PubMed ID: 36434961
[TBL] [Abstract][Full Text] [Related]
18. A Multiview Clustering Method With Low-Rank and Sparsity Constraints for Cancer Subtyping.
Zhanpeng H; Jiekang W
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(6):3213-3223. PubMed ID: 34705654
[TBL] [Abstract][Full Text] [Related]
19. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
20. Statistical Methods for Integrative Clustering of Multi-omics Data.
Chalise P; Kwon D; Fridley BL; Mo Q
Methods Mol Biol; 2023; 2629():73-93. PubMed ID: 36929074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
